Abstract:BACKGROUND & AIMS: Transforming growth factor (TGF)-beta-activated kinase 1 (TAK1) is activated in different cytokine signaling pathways. Deletion of Tak1 from hepatocytes results in spontaneous development of hepatocellular carcinoma (HCC), liver inflammation, and fibrosis. TGF-beta activates TAK1 and Smad signaling, which regulate cell death, proliferation, and carcinogenesis. However, it is not clear whether TGF-beta signaling in hepatocytes, via TGF-beta receptor-2 (Tgfbr2), promotes HCC and liver fibrosis. METHODS: We generated mice with hepatocyte-specific deletion of Tak1 (Tak1 Delta Hep), as well as Tak1/Tgfbr2DHep and Tak1/Smad4 Delta Hep mice. Tak1flox/flox, Tgfbr2 beta Hep, and Smad4 Delta Hep mice were used as controls, respectively. We assessed development of liver injury, inflammation, fibrosis, and HCC. Primary hepatocytes isolated from these mice were used to assess TGF-beta-mediated signaling. RESULTS: Levels of TGF-beta, TGF-beta R2, and phospho-Smad2/3 were increased in HCCs from Tak1 Delta Hep mice, which developed liver fibrosis and inflammation by 1 month and HCC by 9 months. However, Tak1/Tgfbr2 Delta Hep mice did not have this phenotype, and their hepatocytes did not undergo spontaneous cell death or compensatory proliferation. Hepatocytes from Tak1 Delta Hep mice incubated with TGF-beta did not activate p38, c-Jun N-terminal kinase, or nuclear factor-beta B; conversely, TGF-beta-mediated cell death and phosphorylation of Smad2/3 were increased, compared with control hepatocytes. Blocking the Smad pathway inhibited TGF-beta-mediated death of Tak1-/- hepatocytes. Accordingly, disruption of Smad4 reduced the spontaneous liver injury, inflammation, fibrosis, and HCC that develops in Tak1 Delta Hep mice. Levels of the anti-apoptotic protein Bcl-xL, beta-catenin, connective tissue growth factor, and vascular endothelial growth factor were increased in HCC from Tak1 Delta Hep mice, but not in HCCs from Tak1/Tgfbr2 Delta Hep mice. Injection of N-nitrosodiethylamine induced HCC formation in wild-type mice, but less in Tgfbr2 Delta Hep mice. CONCLUSIONS: TGF-beta promotes development of HCC in Tak1 Delta Hep mice by inducing hepatocyte apoptosis and compensatory proliferation during early phases of tumorigenesis, and inducing expression of anti-apoptotic, pro-oncogenic, and angiogenic factors during tumor progression.

Deletion of HNF1α in Hepatocytes Results in Fatty Liver‐related Hepatocellular Carcinoma in Mice

Hepatic Loss of Lissencephaly 1 (lis1) Induces Fatty Liver and Accelerates Liver Tumorigenesis in Mice.

Hnf6 Promotes Tumor Growth In Colorectal Cancer And Enhances Liver Metastasis In Mouse Model

An HNF1α-regulated Feedback Circuit Modulates Hepatic Fibrogenesis Via the Crosstalk Between Hepatocytes and Hepatic Stellate Cells.

Hepatocarcinogenesis in FXR−/− Mice Mimics Human HCC Progression That Operates Through HNF1α Regulation of FXR Expression

Deletion of Ifn Gamma Enhances Hepatocarcinogenesis in Fxr Knockout Mice

HAF prevents hepatocyte apoptosis and progression to MASH and hepatocellular carcinoma through transcriptional regulation of the NF-κB pathway

Dominant-negative HNF1 mutant promotes liver steatosis and inflammation by regulating hepatic complement factor D

Distinct Role of Interleukin-6 and Tumor Necrosis Factor Receptor-1 in Oval Cell- Mediated Liver Regeneration and Inflammation-Associated Hepatocarcinogenesis

HAF prevents hepatocyte apoptosis and progression to MASH and HCC through transcriptional regulation of the NF-κB pathway

Hepatocyte Nuclear Factor 4 Alpha Suppresses the Development of Hepatocellular Carcinoma

Fat-1 Mice Prevent High-Fat Plus High-Sugar Diet-Induced Non-Alcoholic Fatty Liver Disease

Liver-specific Inactivation of the Nrf1 Gene in Adult Mouse Leads to Nonalcoholic Steatohepatitis and Hepatic Neoplasia

Conditional Disruption of Axin1 Leads to Development of Liver Tumors in Mice

NFATc1 is a Tumor Suppressor in Hepatocellular Carcinoma and Induces Tumor Cell Apoptosis by Activating the FasL‐mediated Extrinsic Signaling Pathway

Hepatocyte CD36 protects mice from NASH diet-induced liver injury and fibrosis via blocking N1ICD production

Hypoxia inducible factor-1 promotes liver fibrosis in nonalcoholic fatty liver disease by activating PTEN/p65 signaling pathway.

HN1-mediated activation of lipogenesis through Akt-SREBP signaling promotes hepatocellular carcinoma cell proliferation and metastasis

Hepatocyte Nuclear Factor 4 Alpha-Nuclear Factor-Kappa B Feedback Circuit Modulates Liver Cancer Progression

TALENs-directed Knockout of the Full-Length Transcription Factor Nrf1α That Represses Malignant Behaviour of Human Hepatocellular Carcinoma (hepg2) Cells.

Transforming Growth Factor–β Signaling in Hepatocytes Promotes Hepatic Fibrosis and Carcinogenesis in Mice with Hepatocyte-Specific Deletion of TAK1